NFE2L2 and Cognitive impairment: On the basis of our results we may conclude that HSCD was significantly associatedwith induction of cognitive impairment in rats, and that treatment with enzymeHMG-CoA reductase inhibitor, rosuvastatin, ameliorated cognitive impairment via itsaction on the Nrf2–ARE pathway.